CoChat

Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Under conditions of limited oxygen availability (hypoxia), multiple cell types release adenine nucleotides in the form of ATP, ADP, and AMP. Extracellular AMP is metabolized to adenosine by surface-expressed ecto-5′-nucleotidase (CD73) and subsequently activates surface adenosine receptors regulating endothelial and epithelial barrier function. Therefore, we hypothesized that hypoxia transcriptionally regulates CD73 expression. Microarray RNA analysis revealed an increase in CD73 and ecto-apyrase CD39 in hypoxic epithelial cells. Metabolic studies of CD39/CD73 function in intact epithelia revealed that hypoxia enhances CD39/CD73 function as much as 6 ± 0.5–fold over normoxia. Examination of the CD73 gene promoter identified at least one binding site for hypoxia-inducible factor-1 (HIF-1) and inhibition of HIF-1α expression by antisense oligonucleotides resulted in significant inhibition of hypoxia-inducible CD73 expression. Studies using luciferase reporter constructs revealed a significant increase in activity in cells subjected to hypoxia, which was lost in truncated constructs lacking the HIF-1 site. Mutagenesis of the HIF-1α binding site resulted in a nearly complete loss of hypoxia-inducibility. In vivo studies in a murine hypoxia model revealed that hypoxia-induced CD73 may serve to protect the epithelial barrier, since the CD73 inhibitor α,β-methylene ADP promotes increased intestinal permeability. These results identify an HIF-1–dependent regulatory pathway for CD73 and indicate the likelihood that CD39/CD73 protects the epithelial barrier during hypoxia.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci0215337

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 6

  1. Mertens, 1990, Am J Physiol, 258, H689
  2. Evans, 2000, Cancer Res, 60, 2018
  3. Minamino, 1996, Am J Physiol, 270, H238
  4. Watanabe, 1992, Am J Physiol, 262, H1174
  5. Comerford, 2002, Cancer Res, 62, 3387
  6. Pinsky, 2002, J Clin Invest, 109, 1031, 10.1172/JCI0210649 · doi:10.1172/jci0210649 · Paper page

Cited by

See all 660

Metadata

Authors
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • University of Washington (US)
  • Oklahoma Medical Research Foundation (US)
Corresponding author
Colgan, Sean P.
Venue
Journal of Clinical Investigation
Published
2002-10-01
Volume
110
Issue
7
Pages
993-1002
ISSN
0021-9738 (ISSN-L)
OpenAlex
W4250417345
Cited by
660
References
51
Citations by year
2026: 12 · 2025: 22 · 2024: 31 · 2023: 36 · 2022: 39 · 2021: 33 · 2020: 44 · 2019: 35 · 2018: 41 · 2017: 38 · 2016: 28 · 2015: 33 · 2014: 32 · 2013: 46 · 2012: 26
FWCI
5.72
Type
journal article
Language
en
Open access
closed
Locations
Journal of Clinical Investigation (publishedVersion)
Funders
  • Crohn's and Colitis Foundation of America
  • Crohn's and Colitis Foundation
  • National Institutes of Health (13499, DE13499, DK-50189)
  • National Heart, Lung, and Blood Institute (R01HL060569)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
ecto-5'-nucleotidase, CD73, CD39, HIF-1, HIF-1α, intestinal permeability, intestinal epithelial barrier, hypoxia, adenosine metabolism, extracellular nucleotides, alpha,beta-methylene ADP, transcriptional regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.